Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TWO
3251
CALL
Two Harbors Investment
TWO
$1.27B
| $6.45M | ﹤0.01% |
324,000
+11,125
| +4% | +$225K |
|
3252
PUT
CryoPort
CYRX
$772M
| $6.45M | ﹤0.01% |
208,100
+102,800
| +98% | +$2.73M |
|
3253
PUT
GlobalFoundries
GFS
$30B
| $6.45M | ﹤0.01% |
159,800
-578,400
| -78% | -$30.6M |
|
3254
PUT
Hormel Foods
HRL
$13.5B
| $6.45M | ﹤0.01% |
136,100
+81,300
| +148% | +$4.06M |
|
3255
CALL
Acadia Pharmaceuticals
ACAD
$4.87B
| $6.44M | ﹤0.01% |
457,200
+325,900
| +248% | +$6.08M |
|
3256
CALL
Charles River Laboratories
CRL
$13.4B
| $6.44M | ﹤0.01% |
30,100
-3,400
| -10% | -$831K |
|
|
MFA
3257
MFA Financial
MFA
$926M
| $6.44M | ﹤0.01% |
598,857
+154,767
| +35% | +$2.08M |
|
3258
NETSCOUT
NTCT
$2.88B
| $6.43M | ﹤0.01% |
189,984
-2,008
| -1% | -$67.4K |
|
3259
Genesco
GCO
$391M
| $6.43M | ﹤0.01% |
+128,817
| New | +$7.72M |
|
3260
CALL
AeroVironment
AVAV
$9.76B
| $6.43M | ﹤0.01% |
78,200
+27,300
| +54% | +$2.43M |
|
3261
Primerica
PRI
$9.65B
| $6.43M | ﹤0.01% |
53,701
+8,384
| +19% | +$1.05M |
|
3262
Cognex
CGNX
$11B
| $6.42M | ﹤0.01% |
+151,017
| New | +$8.46M |
|
|
SFR
3263
DELISTED
Appreciate Holdings, Inc. Class A Common Stock
SFR
| $6.42M | ﹤0.01% |
650,195
-500,097
| -43% | -$4.92M |
|
3264
XP
XP
$8.17B
| $6.42M | ﹤0.01% |
357,283
+123,352
| +53% | +$2.84M |
|
3265
PUT
Molina Healthcare
MOH
$11.1B
| $6.4M | ﹤0.01% |
22,900
-9,800
| -30% | -$2.96M |
|
|
BLTS
3266
DELISTED
Bright Lights Acquisition Corp. Class A Common Stock
BLTS
| $6.4M | ﹤0.01% |
650,601
-565
| -0.1% | -$5.57K |
|
3267
CALL
ProShares UltraShort Bloomberg Natural Gas
KOLD
$105M
| $6.4M | ﹤0.01% |
319,720
+274,170
| +602% | +$4.36M |
|
|
ITQ
3268
DELISTED
Itiquira Acquisition Corp. Class A Ordinary Shares
ITQ
| $6.4M | ﹤0.01% |
650,175
+131
| +0% | +$1.29K |
|
3269
Hasbro
HAS
$13.6B
| $6.39M | ﹤0.01% |
78,079
-229,640
| -75% | -$19.9M |
|
|
ACH
3270
Accendra Health
ACH
$73.1M
| $6.39M | ﹤0.01% |
203,052
+162,435
| +400% | +$5.88M |
|
|
SUM
3271
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $6.38M | ﹤0.01% |
278,766
-288,499
| -51% | -$7.66M |
|
3272
PUT
iShares MSCI Mexico ETF
EWW
$1.86B
| $6.38M | ﹤0.01% |
137,000
+41,300
| +43% | +$2.07M |
|
|
LHC
3273
DELISTED
Leo Holdings Corp. II
LHC
| $6.37M | ﹤0.01% |
646,291
-998,145
| -61% | -$9.81M |
|
3274
CALL
Otis Worldwide
OTIS
$27.6B
| $6.37M | ﹤0.01% |
90,100
+45,000
| +100% | +$3.31M |
|
|
OPTU
3275
PUT
Optimum Communications Inc
OPTU
$251M
| $6.35M | ﹤0.01% |
686,700
+466,900
| +212% | +$4.89M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.